Complete Story
 

Learning Objectives OPA Home Study Educational Programming: Patient Safety, Law & Immunization

Objectives for OPF Home-Study Continuing Education

Patient/Medication Safety Home-Study CPE

Recognizing and Preventing Vaccine Errors
ACPE Program #0129-0000-17-006-H05-P
Objectives. At the completion of this activity, the participant will be able to:

1. demonstrate an understanding of the process to submit errors to the Institute for Safe Medication Practices (ISMP) National Vaccine Errors Reporting Program (VERP);
2. list types of vaccine errors reported and commonly associated with vaccines;
3. recognize strategies to minimize vaccine-related errors;
4. identify workplace policy and procedures and strategies that can help minimize the risk of errors; and
5. list missed opportunities related to potential vaccine-related errors.

A New Generation of Medical Errors with the Rise of Health Information Technology
ACPE #0129-0000-16-007-H05-P
Objectives. At the completion of this activity, the participant will be able to:

1. demonstrate an understanding of the rationale for the continued development and implementation of electronic prescribing in community pharmacies and across other health systems;
2. list advantages of utilization of electronic prescribing in community pharmacies;
3. identify drawbacks, common sources of errors, and workflow issues related to electronic prescribing; and
4. recognize solutions for identifying and resolving medication-related errors associated with electronic prescribing and for reducing alert fatigue.

---

Law Home-Study CPE

Important Updates to Ohio Pharmacy Laws and Rules
ACPE #0129-0000-17-102-H03-P
Objectives. At the completion of this activity, the participant will be able to:

1. recognize the new requirements for prescribers to treat acute pain with opioids and the pharmacist’s corresponding responsibility;
2. list the requirements for a pharmacy technician to qualify as a registered pharmacy technician or a certified pharmacy technician by the State of Ohio Board of Pharmacy under Ohio Revised Code; and
3. demonstrate an understanding of the authorization process, protocol requirements, and procedures for a pharmacist to administer dangerous drugs to patients by injection.

Legal Requirements for Buprenorphine for Opioid Addiction
ACPE #0129-0000-17-013-H03-P
Objectives. At the completion of this activity, the participant will be able to:

1. recognize the rise of opioid overdose deaths particularly from the upsurge of heroin usage;
2. identify steps taken to decrease the supply of prescription opioids to treat pain in Ohio;
3. exhibit knowledge of the evolution of medication-assisted treatment (MAT) programs;
4. outline the legal requirements for Office Based Opioid Treatment utilizing buprenorphine-containing products; and
5. demonstrate an understanding of the scope and methods of diversion of buprenorphine-containing products and steps the pharmacist can take to combat them.

Pharmacy Law: Legislative and Regulatory Update 2015-2016
ACPE #0129-0000-16-013-H03-P
Objectives. At the completion of this activity, the participant will be able to:

1. identify recent changes in pharmacy law and rule to expand pharmacy practice in the areas of physician consult agreements, naloxone dispensing, and pharmacist-administered immunizations;
2. demonstrate an understanding of dispensing changes in the criteria for mandatory obtaining of OARRS reports, compounding, emergency medication supplies, and expedited partner therapy; and
3. list the new requirements for pharmacist license renewal.

Legislative and Regulatory Interventions to Combat Opioid Abuse
ACPE #0129-0000-16-013-H03-P
Objectives. At the completion of this activity, the participant will be able to:

1. demonstrate an understanding of the basic pharmacology of naloxone, available products, and rationale for use in opioid overdoses;
2. list the provisions of recent legislation in Ohio which permits a pharmacist to dispense naloxone without a prescription;
3. outline recent changes in criteria for increased OARRS monitoring; and
4. explain how legislative and regulatory efforts have affected opioid overdose deaths in Ohio.

---

Immunization Home-Study Offerings

Immunizations for Selected Vaccine-Preventable Diseases
ACPE# 0129-0000-17-014-H01-P
Objectives. At the completion of this activity, the participant will be able to:

1. exhibit knowledge of the immune system, types of antigens, and types of immunity;
2. identify effective immunization strategies for prevention of influenza, pneumonia, hepatitis A & B, meningitis, tetanus, diphtheria, pertussis, herpes zoster, measles, mumps, and rubella in at-risk populations, and the roles of health care providers;
3. demonstrate an understanding of the currently available vaccines for the diseases discussed, including indications, dosing recommendations, contraindications and precautions, adverse reactions, and storage requirements;
4. outline appropriate monitoring and treatment of the vaccine for adverse reactions including the use of epinephrine and diphenhydramine;
5. recognize how to report vaccine adverse events; and
6. list key sources for current information on vaccines.

Immunizations for Typhoid, Yellow Fever, Japanese Encephalitis, Cholera and Rabies
ACPE #0129-0000-16-120-H01-P
Objectives.  At the completion of this activity, the participant will be able to:

1. identify persons who should be vaccinated with typhoid, yellow fever, Japanese encephalitis, cholera and rabies vaccines;
2. recognize the epidemiology and signs and symptoms of each disease; and
3. list dosage, route of administration, adverse reactions, contraindications and storage requirements for each vaccine.
   

Immunizations for HPV, Varicella, Hib, and Polio
ACPE #0129-0000-15-062-H01-P
Objectives.  At the completion of this activity, the participant will be able to:

1. identify the diseases caused by human papillomavirus (HPV), varicella, Haemophilus influenzae type b (Hib), and polio; and state the epidemiology of these vaccine-preventable diseases;
2. list the recommendations for immunization of patients seven years of age or older for these vaccines, including appropriate patient populations, doses, route of administration, and injection sites;
3. recognize the precautions, contraindications, and adverse reactions associated with these vaccines, as well as monitoring and treatment of patients with adverse reactions; and
4. list the storage and handling requirements of HPV, varicella, Hib, and polio vaccines.

---

Long-Acting Injectables Home-Study Offerings

Injectable Cobalamin Review for Pharmacists
ACPE #0129-0000-18-066-H01-P
Objectives. At the completion of this activity, the participant will be able to:

1. identify the mechanism of action of cobalamin and etiology of cobalamin deficiency;
2. demonstrate an understanding of appropriate treatment of cobalamin deficiency, including affected patient populations, dosages, administration schedules, routes of administration, and storage;
3. list adverse reactions, precautions, and contraindications of cobalamin injections, as well as monitoring and treatment of patients who experience an allergic reaction; and
4. recognize patient concerns that may arise, including patient privacy and storage of patient's prescriptions in the pharmacy.

Injectable Medroxyprogesterone Acetate Review for Pharmacists
ACPE #0129-0000-18-067-H01-P
Objectives. At the completion of this activity, the participant will be able to:

1. recognize the therapeutic role of medroxyprogesterone acetate in contraception;
2. identify pharmacokinetic and pharmacodynamic properties of medroxyprogesterone acetate;
3. list precautions, contraindications, and adverse reactions of medroxyprogesterone acetate; and recognize appropriate treatment for severe allergic reactions; and
4. demonstrate an understanding of the appropriate dosing and administration of medroxyprogesterone acetate.

Injectable Hydroxyprogesterone Caproate Review for Pharmacists
ACPE #0129-0000-18-068-H01-P
Objectives. At the completion of this activity, the participant will be able to:

1. identify patients who are indicated to receive hydroxyprogesterone caproate injection;
2. identify contraindications to hydroxyprogesterone caproate therapy;
3. demonstrate an understanding of proper storage and administration of hydroxyprogesterone caproate injection; and
4. recognize common adverse reactions associated with hydroxyprogesterone injections and how to manage them.

Long-Acting Injectable Antipsychotics Review for Pharmacists
ACPE #0129-0000-18-069-H01-P
Objectives. At the completion of this activity, the participant will be able to:

1. recognize the therapeutic role of long-acting injectable antipsychotics and demonstrate an understanding of the disorders they are used to treat;
2. demonstrate an understanding of mechanisms of action and appropriate dosing and administration of long-acting injectable antipsychotics;
3. list precautions, contraindications, and adverse reactions of long-acting injectable antipsychotics; and recognize appropriate treatment for severe allergic reactions; and
4. recognize the importance of acute and chronic monitoring for these medications.

Injectable Naltrexone Review for Pharmacists
ACPE #0129-0000-18-070-H01-P
Objectives. At the completion of this activity, the participant will be able to:

1. recognize the therapeutic role of naltrexone in, and evidence for, treatment of alcohol use and opioid use disorders;
2. identify the mechanisms of action and appropriate dosing and administration of extended-release injectable naltrexone;
3. list precautions, contraindications, and adverse reactions of extended-release injectable naltrexone; and recognize appropriate treatment for adverse reactions; and
4. demonstrate an understanding of the monitoring, special populations and storage of extended-release injectable naltrexone.

Printer-Friendly Version